Iranian Journal of Pediatrics

Published by: Kowsar
Uncorrected Proof scheduled for 29 (3)

Neuroblastoma Characteristics and Embryonic Origin of The Primary Lesion Site: A SEER Study

Jiaxi He # 1 , Shaochang Wu # 2 , Na Zhu 3 , Chunjiao Rong 3 , Tielun Yan 3 and Xiumei Yan ORCID 3 , *
Authors Information
1 Department of Thoracic Surgery, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China
2 Department of Geriatric, The Second People' Hospital of Lishui, Zhejiang, China
3 Department of Clinical Lab, The Second People' Hospital of Lishui, Zhejiang, China
# These authors are contributed equally as the first author.
Article information
  • Iranian Journal of Pediatrics: In Press (In Press); e85676
  • Published Online: June 10, 2019
  • Article Type: Research Article
  • Received: October 23, 2018
  • Revised: March 4, 2019
  • Accepted: March 8, 2019
  • DOI: 10.5812/ijp.85676

To Cite: He J , Wu S , Zhu N , Rong C , Yan T , et al. Neuroblastoma Characteristics and Embryonic Origin of The Primary Lesion Site: A SEER Study, Iran J Pediatr. Online ahead of Print ; In Press(In Press):e85676. doi: 10.5812/ijp.85676.

Copyright © 2019, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Ahmed AA, Zhang L, Reddivalla N, Hetherington M. Neuroblastoma in children: Update on clinicopathologic and genetic prognostic factors. Pediatr Hematol Oncol. 2017;34(3):165-85. doi: 10.1080/08880018.2017.1330375. [PubMed: 28662353].
  • 2. Granata C, Fagnani AM, Gambini C, Boglino C, Bagnulo S, Cecchetto G, et al. Features and outcome of neuroblastoma detected before birth. J Pediatr Surg. 2000;35(1):88-91. [PubMed: 10646781].
  • 3. Gallik KL, Treffy RW, Nacke LM, Ahsan K, Rocha M, Green-Saxena A, et al. Neural crest and cancer: Divergent travelers on similar paths. Mech Dev. 2017;148:89-99. doi: 10.1016/j.mod.2017.08.002. [PubMed: 28888421]. [PubMed Central: PMC5811199].
  • 4. Luksch R, Castellani MR, Collini P, De Bernardi B, Conte M, Gambini C, et al. Neuroblastoma (Peripheral neuroblastic tumours). Crit Rev Oncol Hematol. 2016;107:163-81. doi: 10.1016/j.critrevonc.2016.10.001. [PubMed: 27823645].
  • 5. Shimada H. Tumors of the neuroblastoma group. Pathology (Phila). 1993;2(1):43-59. [PubMed: 9420930].
  • 6. Davidoff AM. Neuroblastoma. Semin Pediatr Surg. 2012;21(1):2-14. doi: 10.1053/j.sempedsurg.2011.10.009. [PubMed: 22248965]. [PubMed Central: PMC3261589].
  • 7. Lee KH, Lee SJ, Lee HJ, Choi GE, Jung YH, Kim DI, et al. Amyloid beta1-42 (Abeta1-42) induces the CDK2-mediated phosphorylation of tau through the activation of the mTORC1 signaling pathway while promoting neuronal cell death. Front Mol Neurosci. 2017;10:229. doi: 10.3389/fnmol.2017.00229. [PubMed: 28790888]. [PubMed Central: PMC5522873].
  • 8. Ambrosio S, Sacca CD, Amente S, Paladino S, Lania L, Majello B. Lysine-specific demethylase LSD1 regulates autophagy in neuroblastoma through SESN2-dependent pathway. Oncogene. 2017;36(48):6701-11. doi: 10.1038/onc.2017.267. [PubMed: 28783174]. [PubMed Central: PMC5717079].
  • 9. Ruffels J, Griffin M, Dickenson JM. Activation of ERK1/2, JNK and PKB by hydrogen peroxide in human SH-SY5Y neuroblastoma cells: Role of ERK1/2 in H2O2-induced cell death. Eur J Pharmacol. 2004;483(2-3):163-73. [PubMed: 14729104].
  • 10. Navalkele P, O'Dorisio MS, O'Dorisio TM, Zamba GK, Lynch CF. Incidence, survival, and prevalence of neuroendocrine tumors versus neuroblastoma in children and young adults: nine standard SEER registries, 1975-2006. Pediatr Blood Cancer. 2011;56(1):50-7. doi: 10.1002/pbc.22559. [PubMed: 21108439]. [PubMed Central: PMC4251713].
  • 11. Huang W. Philosophical thinking and practice of tumor physical immunity-design thinking of “millimeter wave therapy to strengthen the immune system”. Open J Nature Sci. 2015;3(3):55-60. doi: 10.12677/ojns.2015.33008.
  • 12. Riccardo F, Real A, Voena C, Chiarle R, Cavallo F, Barutello G. Maternal immunization: New perspectives on its application against non-infectious related diseases in newborns. Vaccines (Basel). 2017;5(3). doi: 10.3390/vaccines5030020. [PubMed: 28763018]. [PubMed Central: PMC5620551].
  • 13. PDQ Pediatric Treatment Editorial Board. Neuroblastoma treatment (PDQ(R)): Patient version. PDQ cancer information summaries. Bethesda (MD): National Cancer Institute (US); 2002. eng.
  • 14. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100(1):57-70. [PubMed: 10647931].
  • 15. Pierce GB. The cancer cell and its control by the embryo. Rous-Whipple Award lecture. Am J Pathol. 1983;113(1):117-24. [PubMed: 6312802]. [PubMed Central: PMC1916304].
  • 16. Maman S, Edry-Botzer L, Sagi-Assif O, Meshel T, Yuan W, Lu W, et al. The metastatic microenvironment: Lung-derived factors control the viability of neuroblastoma lung metastasis. Int J Cancer. 2013;133(10):2296-306. doi: 10.1002/ijc.28255. [PubMed: 23649556].
  • 17. Pistoia V, Morandi F, Bianchi G, Pezzolo A, Prigione I, Raffaghello L. Immunosuppressive microenvironment in neuroblastoma. Front Oncol. 2013;3:167. doi: 10.3389/fonc.2013.00167. [PubMed: 23805414]. [PubMed Central: PMC3693127].
  • 18. Pinto NR, Applebaum MA, Volchenboum SL, Matthay KK, London WB, Ambros PF, et al. Advances in risk classification and treatment strategies for neuroblastoma. J Clin Oncol. 2015;33(27):3008-17. doi: 10.1200/JCO.2014.59.4648. [PubMed: 26304901]. [PubMed Central: PMC4567703].
  • 19. Pai Panandiker AS, Beltran C, Billups CA, McGregor LM, Furman WL, Davidoff AM. Intensity modulated radiation therapy provides excellent local control in high-risk abdominal neuroblastoma. Pediatr Blood Cancer. 2013;60(5):761-5. doi: 10.1002/pbc.24350. [PubMed: 23024112].
  • 20. Platek ME, Merzianu M, Mashtare TL, Popat SR, Rigual NR, Warren GW, et al. Improved survival following surgery and radiation therapy for olfactory neuroblastoma: Analysis of the SEER database. Radiat Oncol. 2011;6:41. doi: 10.1186/1748-717X-6-41. [PubMed: 21518449]. [PubMed Central: PMC3098784].
  • 21. Kandula S, Prabhu RS, Nanda R, Switchenko JM, Cash T, Qayed M, et al. Outcomes after radiation therapy to metastatic sites in patients with stage 4 neuroblastoma. J Pediatr Hematol Oncol. 2015;37(3):175-80. doi: 10.1097/MPH.0000000000000264. [PubMed: 25238225]. [PubMed Central: PMC4869887].
  • 22. Ducassou A, Gambart M, Munzer C, Padovani L, Carrie C, Haas-Kogan D, et al. Long-term side effects of radiotherapy for pediatric localized neuroblastoma: Results from clinical trials NB90 and NB94. Strahlenther Onkol. 2015;191(7):604-12. doi: 10.1007/s00066-015-0837-z. [PubMed: 25896312].
  • 23. Andries V, Vandepoele K, Staes K, Berx G, Bogaert P, Van Isterdael G, et al. NBPF1, a tumor suppressor candidate in neuroblastoma, exerts growth inhibitory effects by inducing a G1 cell cycle arrest. BMC Cancer. 2015;15:391. doi: 10.1186/s12885-015-1408-5. [PubMed: 25958384]. [PubMed Central: PMC4440459].
  • 24. Chikaraishi K, Takenobu H, Sugino RP, Mukae K, Akter J, Haruta M, et al. CFC1 is a cancer stemness-regulating factor in neuroblastoma. Oncotarget. 2017;8(28):45046-59. doi: 10.18632/oncotarget.18464. [PubMed: 28620148]. [PubMed Central: PMC5542166].
  • 25. Tsubota S, Kadomatsu K. Neuroblastoma stem cells and CFC1. Oncotarget. 2017;8(28):45032-3. doi: 10.18632/oncotarget.18491. [PubMed: 28636551]. [PubMed Central: PMC5542159].
  • 26. Delloye-Bourgeois C, Bertin L, Thoinet K, Jarrosson L, Kindbeiter K, Buffet T, et al. Microenvironment-driven shift of cohesion/detachment balance within tumors induces a switch toward metastasis in neuroblastoma. Cancer Cell. 2017;32(4):427-43 e8. doi: 10.1016/j.ccell.2017.09.006. [PubMed: 29017055].
  • 27. Pugh TJ, Morozova O, Attiyeh EF, Asgharzadeh S, Wei JS, Auclair D, et al. The genetic landscape of high-risk neuroblastoma. Nat Genet. 2013;45(3):279-84. doi: 10.1038/ng.2529. [PubMed: 23334666]. [PubMed Central: PMC3682833].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments